The levothyroxine and liothyronine tablets, manufactured by Westminster Pharmaceuticals LLC, were sold wholesale in 100-count bottles. They used active ingredients sourced before the FDA issued an import alert about Sichuan Friendly Pharmaceutical Co. Ltd., officials said. The alert warned that a 2017 inspection found that the company deviated from current good manufacturing practices, putting the quality of ingredients at risk.
Officials with Westminster Pharmaceuticals said that as of Aug. 9, they had no reports of illnesses connected to the recall. The company warned that patients taking the recalled medications should continue to do so, at least until discussing options with their doctors.